Follow
Ben Li
Title
Cited by
Cited by
Year
Detection of differentially methylated regions from whole-genome bisulfite sequencing data without replicates
H Wu, T Xu, H Feng, L Chen, B Li, B Yao, Z Qin, P Jin, KN Conneely
Nucleic acids research 43 (21), e141-e141, 2015
3082015
Randomized clinical trial of pembrolizumab vs chemotherapy for previously untreated Chinese patients with PD‐L1‐positive locally advanced or metastatic non–small‐cell lung …
YL Wu, L Zhang, Y Fan, JY Zhou, L Zhang, Q Zhou, W Li, CP Hu, ...
International journal of cancer 148 (9), 2313-2320, 2021
782021
Base-resolution methylation patterns accurately predict transcription factor bindings in vivo
T Xu, B Li, M Zhao, KE Szulwach, RC Street, L Lin, B Yao, F Zhang, P Jin, ...
Nucleic acids research 43 (5), 2757-2766, 2015
482015
KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer
DP Petrylak, R Ratta, R Gafanov, G Facchini, JM Piulats, G Kramer, ...
Future Oncology, 2021
46*2021
Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407
Y Cheng, L Zhang, J Hu, D Wang, CP Hu, J Zhou, L Wu, L Cao, J Liu, ...
JTO clinical and research reports 2 (10), 100225, 2021
302021
Direct amplification, sequencing and profiling of Chlamydia trachomatis strains in single and mixed infection clinical samples
SJ Joseph, B Li, T Ghonasgi, CP Haase, ZS Qin, D Dean, TD Read
PloS one 9 (6), e99290, 2014
292014
Direct amplification, sequencing and profiling of Chlamydia trachomatis strains in single and mixed infection clinical samples
SJ Joseph, B Li, T Ghonasgi, CP Haase, ZS Qin, D Dean, TD Read
PloS one 9 (6), e99290, 2014
292014
Direct amplification, sequencing and profiling of Chlamydia trachomatis strains in single and mixed infection clinical samples
SJ Joseph, B Li, T Ghonasgi, CP Haase, ZS Qin, D Dean, TD Read
PloS one 9 (6), e99290, 2014
292014
Rapid irreversible transcriptional reprogramming in human stem cells accompanied by discordance between replication timing and chromatin compartment
V Dileep, KA Wilson, C Marchal, X Lyu, PA Zhao, B Li, A Poulet, ...
Stem cell reports 13 (1), 193-206, 2019
242019
Reliability of environmental sampling culture results using the negative binomial intraclass correlation coefficient
SS Aly, J Zhao, B Li, J Jiang
SpringerPlus 3, 1-7, 2014
192014
Statistical challenges in analyzing methylation and long-range chromosomal interaction data
Z Qin, B Li, KN Conneely, H Wu, M Hu, D Ayyala, Y Park, VX Jin, F Zhang, ...
Statistics in biosciences 8, 284-309, 2016
152016
A comprehensive review of computational prediction of genome-wide features
T Xu, X Zheng, B Li, P Jin, Z Qin, H Wu
Briefings in bioinformatics 21 (1), 120-134, 2020
142020
Bayesian inference with historical data-based informative priors improves detection of differentially expressed genes
B Li, Z Sun, Q He, Y Zhu, ZS Qin
Bioinformatics 32 (5), 682-689, 2016
142016
MA11. 02 KEYNOTE-042 China Study: First-Line Pembrolizumab vs Chemotherapy in Chinese Patients with Advanced NSCLC with PD-L1 TPS≥ 1%
Y Wu, L Zhang, Y Fan, J Zhou, Q Zhou, W Li, C Hu, G Chen, X Zhang, ...
Journal of Thoracic Oncology 14 (10), S290-S291, 2019
122019
RT States: systematic annotation of the human genome using cell type-specific replication timing programs
A Poulet, B Li, T Dubos, JC Rivera-Mulia, DM Gilbert, ZS Qin
Bioinformatics 35 (13), 2167-2176, 2019
122019
The single-species metagenome: subtyping Staphylococcus aureus core genome sequences from shotgun metagenomic data
SJ Joseph, B Li, RA Petit III, ZS Qin, L Darrow, TD Read
PeerJ 4, e2571, 2016
102016
KEYNOTE‐033: Randomized phase 3 study of pembrolizumab vs docetaxel in previously treated, PD‐L1‐positive, advanced NSCLC
S Ren, J Feng, S Ma, HJ Chen, Z Ma, C Huang, L Zhang, J He, C Wang, ...
International Journal of Cancer 153 (3), 623-634, 2023
62023
1262P Randomized, open-label phase III study of pembrolizumab (pembro) vs docetaxel (doce) in patients (pts) with previously treated NSCLC with PD-L1 tumour proportion score …
C Zhou, J Feng, S Ma, H Chen, Z Ma, C Huang, L Zhang, J He, C Wang, ...
Annals of Oncology 31, S816, 2020
62020
Phase III study of pembrolizumab (pembro) plus docetaxel and prednisone for enzalutamide (enza)-or abiraterone acetate (abi)–pretreated patients (pts) with metastatic …
DP Petrylak, ND Shore, M Bennamoun, R Ratta, JM Piulats, B Li, ...
Journal of Clinical Oncology 38 (6_suppl), TPS262-TPS262, 2020
52020
KEYNOTE-921: Phase III study of pembrolizumab (pembro) plus docetaxel and prednisone for enzalutamide (enza)-or abiraterone (abi)-pretreated patients (pts) with metastatic …
DP Petrylak, B Li, C Schloss, K Fizazi
Annals of Oncology 30, v351, 2019
42019
The system can't perform the operation now. Try again later.
Articles 1–20